Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Operating activities:
Net loss	$ (13,603)	$ (8,831)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities, net of effect of business acquisitions:
Depreciation and amortization	1,650	1,053
Gain on sale of marketable securities	(9)	(192)
Share based compensation expense	50	(1,197)
Non-cash compensation	782	201
Provision for doubtful accounts	551	331
Gain on sale of assets	(112)	(83)
Deferred income tax	69	73
Impairment of goodwill	191	192
Amortization of debt discount	383	0
Deferred rent amortization	104	0
Forgiveness of receivable	174	0
Changes in certain assets and liabilities:
Accounts receivable	(533)	(1,034)
Inventory	823	1,000
Other current assets	587	628
Accounts payable	(389)	(1,139)
Related party payables	194	1,268
Accrued commissions	1,364	863
Accrued liabilities	538	2,002
Deferred revenue	574	(468)
Taxes payable	764	(618)
Other liabilities	(6)	(450)
Net cash used in operating activities	(5,854)	(6,401)
Investing activities:
Capital expenditures	(61)	(332)
Proceeds from the sale of property, plant and equipment	141	60
Purchases of marketable securities	0	(18,876)
Proceeds from sales of marketable securities	4,073	13,901
Proceeds from note receivable	0	2
Deposit of restricted cash collateral	0	(2,931)
Acquisitions, net of cash purchased	0	(3,135)
Net cash (used in) provided by investing activities	4,153	(11,311)
Financing activities:
Borrowings on long-term debt	0	3,051
Payments on long-term debt	(941)	(471)
Stock issuances	274	18,434
Net cash (used in) provided by financing activities	(667)	21,014
Effect of exchange rate changes on cash and cash equivalents	(1,918)	(195)
Increase (decrease) in cash and cash equivalents	(4,286)	3,107
Cash and cash equivalents at beginning of period	6,482	2,606
Cash and cash equivalents at end of period	2,196	5,713
Cash paid during the period for:
Interest	1,858	1,164
Income taxes	342	313
Non-cash transactions:
Stock issued related to expenses	$ 274	$ 0